Based on these results, VDR is necessary to activate the Nrf2/HO-1 signaling pathway and that eriodictyol reduces memory impairment in Alzheimer’s disease by inhibiting ferroptosis. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.